decitabine

Ukraine

Drugs containing this active substance

  • DECINJET

    The drug is intended for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are not candidates for standard induction chemotherapy.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    decitabine 50 mg

    ATC: L01BC08

    Manufacturer: Eugia Pharma Specialities Limited

  • The drug is intended for the treatment of adult patients with newly diagnosed or secondary acute myeloid leukemia (AML) who are not candidates for standard induction chemotherapy.

    Form: powder for solution for infusion

    Active substance Dosage
    decitabine 50 mg

    ATC: L01BC08

    Manufacturer: San Pharmaceutical Industries Ltd.

  • The drug is indicated for the treatment of adult patients with newly diagnosed or secondary acute myeloid leukemia (AML) who, according to the WHO classification, are not candidates for standard induction chemotherapy.

    Form: lyophilisate for solution for injection

    Active substance Dosage
    decitabine 50 mg

    ATC: L01BC08

    Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))